0169-0084 : Prandin 2 mg Oral Tablet


NDC0169-0084
Labeler: Novo Nordisk
Product Type: Human Prescription Drug
Drug Name:  Prandin
Dosage Form: Oral Tablet
Application #: NDA020741
Rev. Date: 


Appearance:


Shapes:  Round
Colors:  Pink
Size (mm): 5
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

(0169-0084) Prandin 2 mg Oral Tablet by Novo Nordisk
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0169-0084-80: 12 TABLET IN 1 BOTTLE, PLASTIC (0169‑0084‑80)
  • 0169-0084-81: 100 TABLET IN 1 BOTTLE, PLASTIC (0169‑0084‑81)
  • 0169-0084-82: 500 TABLET IN 1 BOTTLE, PLASTIC (0169‑0084‑82)

Active Ingredients:

  • Repaglinide

Dosage Strength:

  • 2 mg

Pharmaceutical Classes:

  • Glinide [EPC]
  • Potassium Channel Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0169-0081 Prandin 0.5 mg Oral Tablet by Novo Nordisk
  • 0169-0082 Prandin 1 mg Oral Tablet by Novo Nordisk
  • 35356-303 Prandin 0.5 mg Oral Tablet by Lake Erie Medical Dba Quality Care Products LLC
  • 49349-559 Prandin 2 mg Oral Tablet by Remedyrepack Inc.
  • 54868-5381 Prandin 2 mg Oral Tablet by Physicians Total Care, Inc.
  • 54868-6439 Prandin 1 mg Oral Tablet by Physicians Total Care, Inc.
  • 55154-4575 Prandin 1 mg Oral Tablet by Cardinal Health
  • 60846-882 Prandin 1 mg/mg Oral Pill by Gemini Laboratories, LLC
  • 60846-884 Prandin 2 mg/mg Oral Pill by Gemini Laboratories, LLC
  • 68151-3565 Prandin .5 mg Oral Tablet by Carilion Materials Management
  • 68151-3566 Prandin 1 mg Oral Tablet by Carilion Materials Management

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0169-0084 QR Code

< Prev: 0169-0082Next: 0169-0092 >

Related Discussions:

Prandimet(metformin and repaglinide
specify availability of Prandimet(metformin and repaglinide) in india....




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.